1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Improving Global Health and Wellbeing in an Era of Transformative AI Request for Proposals is sponsored by Coefficient Giving (Global Health and Wellbeing Opportunities Fund). Supports research, policy, implementation, and field-building to help ensure AI improves human health and wellbeing, with particular attention to risks for and benefits to the global poor.
Get alerted about grants like this
Get emailed when new opportunities from “Coefficient Giving (Global Health and Wellbeing Opportunities Fund)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Coefficient Giving RFP: Global Health and Wellbeing in an Era of Transformative AI — EA Forum Coefficient Giving RFP: Global Health and Wellbeing in an Era of Transformative AI by Coefficient Giving , Deena Mousa Global health & development Opportunities to take action Transformative artificial intelligence Frontpage Coefficient Giving RFP: Global Health and Wellbeing in an Era of Transformative AI A few examples of what a transformative AI future might look like in terms of R&D and health: By Deena Mousa , Program Officer, Global Health & Wellbeing Cause Prioritization AI is progressing rapidly and could have profound implications for the health and wellbeing of people around the world.
While global health philanthropy has historically assumed relative continuity with the past, we would like to engage seriously with the potential implications of transformative AI.
This RFP supports rigorous and cost-effective research, policy development, field-building, and implementation focused on improving health and economic outcomes for individuals in measurable ways that are responsive to both the challenges and opportunities that a world transformed by AI might bring. Please see the example projects below.
This RFP is responsive to the possibility that AI reshapes which global health problems are tractable and where the highest-impact opportunities lie. That said, we think the questions core to global health work remain the same: who is helped, by how much, at what cost, and compared to what alternative?
A few examples of what a transformative AI future might look like in terms of R&D and health: A "compressed 21st century" in biomedicine . AI could compress many decades of biological progress into a few years, delivering cures or effective treatments for a wide range of diseases.
The binding constraint would then shift from scientific discovery to regulatory approval and distribution, particularly to ensure new treatments reach the global poor. A shift in where R&D bottlenecks are .
AI may accelerate stages of the biomedical pipeline unequally — for example by dramatically speeding up literature synthesis, target identification, and molecular design, while leaving wet-lab work, clinical trials, regulatory review, and manufacturing scale-up much less affected.
Some investments important in this world have long lead times, like clinical trial infrastructure in low- and middle-income countries (LMICs), regulatory approval capacity, and data infrastructure that represents underrepresented populations. AI drives explosive economic growth .
If AI automates R&D and a substantial share of labor, rapidly eliminating global poverty could become technically possible, but the distribution of those gains would not be guaranteed. AI erases a rung of the canonical development ladder.
AI could widen disparities between LMICs and advanced economies through vectors like accelerating reshoring, reducing foreign direct investment, and closing off service exports as remote work is automated. The demographic dividend in places like South Asia and sub-Saharan Africa risks becoming a liability as labor tax bases shrink and the financial foundations of health and welfare systems weaken.
We think there’s significant uncertainty about which world we actually end up in, and what the second- and third-order consequences look like. We don’t expect to resolve that uncertainty (or for applicants to do so either!) But we believe that seeding a field of work that engages with this range of possibilities is valuable.
We think LMICs will likely be especially vulnerable to the downsides and especially poorly positioned to capture the upsides. That said, we are fully open to work focused on high-income countries, provided it is responsive to the broader orientation above.
We are excited about funding projects along two complementary axes: identifying the preparatory steps GHW-oriented funders and actors should be taking (research, policy analysis, empirical mapping), and executing on preparatory steps that look high-value (infrastructure, relationships, field-building, piloting). We're particularly interested in seeding new organizations or bringing new people into this area.
And because there is significant uncertainty about how transformative AI scenarios could develop, we're more interested in getting people working on key aspects of the problem than in funding prespecified research projects.
Examples of grants we might fund include: A biopharma pipeline bottleneck map from a practitioner with operating R&D experience A quarterly tracker of AI's labor market effects in business process and software outsourcing sectors in exposed LMICs A policy fellowship embedded at a multilateral or LMIC government body Seed funding for a new organization focused on IP and access frameworks for AI-discovered therapeutics A small team doing pre-launch governance work for a Gavi- or Global Fund-style institution focused on ensuring AI benefits reach the global poor We’re not planning to fund the following through this RFP: Interventions that deploy AI in areas like health, education, or agriculture directly; we plan to continue supporting those through our regular grantmaking.
Work focused primarily on the catastrophic-risk end of the AI transition (such as extinction-level threats); that work falls under our Navigating Transformative AI fund . For more information about how we evaluate potential funding decisions, please see our post on Importance, Neglectedness, and Tractability .
You can also read about how we quantify impact , though we don't expect you to do anything like this as part of your application.
Because we assess grants through their expected impact on health and economic prosperity, research or writing proposals should clearly articulate how the work leads to direct real-world impact (for example, a project may be very likely to inform a particular stakeholder making a particular decision where the wrong decision would have significant negative impact).
We care about this beyond the strength of the research proposal itself and are unlikely to fund research without a clear path to impact. Grants are tiered by size, and the process differs accordingly: Exploratory grants (under $100k): Research and writing projects, scoping studies, prototypes of potential future work, short-form policy work. We will aim to get back to you as soon as possible.
Standard grants ($100k-$1m): New hires at an existing organization, larger research programs, or launching a small (1-3 person) organization. We will reach out with next steps, which may include follow-up questions or a direct decision. Major grants ($1m-$10m): Larger new organizations, institutional capacity-building, substantive policy engagement, or larger preparatory infrastructure.
This is the first stage of the process; we will review applications monthly and invite select applicants to submit a full proposal. By default, grants will usually last two years. Renewability will depend on the nature of the project.
We're open to even larger proposals, though these would be considered outside this RFP process. Eligibility : Open globally to individuals, academic institutions, think tanks, nonprofits, and (where structured appropriately) for-profit entities. We welcome applicants based in, or with deep working knowledge of, LMICs, and applicants who have not previously worked on AI futures.
Proposals to spin up new organizations are in scope. Confidentiality: If we’re unable to provide support but think your project is promising, we may share your application materials with other funders who may be interested. Let us know if you’d prefer we not do this.
We plan to accept applications until August 21 . You can apply through this form . No comments on this post yet.
More from Coefficient Giving Curated and popular this week
According to the current listing, eligibility includes: Open globally to individuals, academic institutions, think tanks, nonprofits, and appropriately structured for-profit entities; welcomes applicants from or with deep knowledge of LMICs. Confirm the full requirements in the official notice before applying.
The current listing shows exploratory grants under $100K; standard grants $100K–$1M; major grants $1M–$10M. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Improving Global Health and Wellbeing in an Era of Transformative AI Request for Proposals are due August 21, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Improving Global Health and Wellbeing in an Era of Transformative AI Request for Proposals is funded by Coefficient Giving (Global Health and Wellbeing Opportunities Fund). Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
CMS awarded all 50 states their first-year slice of the $50 billion Rural Health Transformation Program in December 2025 — from $147M in New Jersey to $281M in Texas. Now the money is moving downstream: New Jersey and New York have already launched subaward RFAs, and rural hospitals, clinics, community organizations, and tribal groups are the eligible applicants. Here is how the allocation formula worked, what the money can and cannot fund, and the strategy to win a state subaward.
Read articleThe FY2026 Rural Health Network Advancement Program (HRSA-26-082) offers six awards of roughly $500,000 to help independent rural hospitals and clinics form integrated networks without surrendering local ownership. With a July 24, 2026 deadline and a pilot design that rewards genuine collaboration over merger, here is who qualifies, what a fundable network looks like, and how small rural providers should approach it.
Read articleThe Elevance Health Foundation's FY2026 Maternal/Infant Health cycle offers grants around $1 million (1–3 years, 15% indirects) to reduce pre-term birth and severe maternal morbidity. But eligibility hinges on a specific 501(c)(3) subsection test, funding concentrates in 10 states plus national scalable programs, and a corporate payer-funder judges you on measurable outcomes, not need. Here is how to read this RFP and compete before the July 31 deadline.
Read article